Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

470 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancer.
Sato T, Oshi M, Huang JL, Chida K, Roy AM, Endo I, Takabe K. Sato T, et al. Among authors: takabe k. Res Sq [Preprint]. 2024 Mar 27:rs.3.rs-4148608. doi: 10.21203/rs.3.rs-4148608/v1. Res Sq. 2024. Update in: Breast Cancer Res Treat. 2024 Nov;208(2):415-427. doi: 10.1007/s10549-024-07434-3 PMID: 38585981 Free PMC article. Updated. Preprint.
Activity-Regulated Cytoskeleton-Associated Protein Gene Expression Is Associated With High Infiltration of Stromal Cells and Immune Cells, but With Less Cancer Cell Proliferation and Better Overall Survival in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers.
Yee G, Wu R, Oshi M, Endo I, Ishikawa T, Takabe K. Yee G, et al. Among authors: takabe k. World J Oncol. 2025 Feb;16(1):16-29. doi: 10.14740/wjon1936. Epub 2025 Jan 13. World J Oncol. 2025. PMID: 39850523 Free PMC article.
Inosine monophosphate dehydrogenase 2 (IMPDH2) modulates response to therapy and chemo-resistance in triple negative breast cancer.
da Silva Fernandes T, Gillard BM, Dai T, Martin JC, Chaudhry KA, Dugas SM, Fisher AA, Sharma P, Wu R, Attwood KM, Dasgupta S, Takabe K, Rosario SR, Bianchi-Smiraglia A. da Silva Fernandes T, et al. Among authors: takabe k. Sci Rep. 2025 Jan 7;15(1):1061. doi: 10.1038/s41598-024-85094-5. Sci Rep. 2025. PMID: 39774345 Free PMC article.
Systemic chemokine-modulatory regimen combined with neoadjuvant chemotherapy in patients with triple-negative breast cancer.
Gandhi S, Slomba RT, Janes C, Fitzpatrick V, Miller J, Attwood K, Ioannou G, Ozbey S, De Souza I, Roudko V, Kumar P, Kalathil S, Kokolus KM, Wang J, Cortes Gomez E, Takabe K, Edge S, Young J, Cappuccino H, Opyrchal M, O'Connor T, Levine EG, Gnjatic S, Kalinski P. Gandhi S, et al. Among authors: takabe k. J Immunother Cancer. 2024 Nov 14;12(11):e010058. doi: 10.1136/jitc-2024-010058. J Immunother Cancer. 2024. PMID: 39542655 Free PMC article. Clinical Trial.
470 results